BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 133 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q4 2018. The put-call ratio across all filers is 0.63 and the average weighting 1.3%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $438,000 | -98.7% | 3,180 | -98.7% | 0.00% | -98.5% |
| Q3 2021 | $33,939,000 | +380.4% | 244,326 | +235.7% | 0.06% | +400.0% |
| Q2 2021 | $7,065,000 | +78400.0% | 72,780 | +52639.1% | 0.01% | – |
| Q1 2021 | $9,000 | -99.9% | 138 | -99.9% | 0.00% | -100.0% |
| Q4 2020 | $9,036,000 | +34.5% | 105,422 | +2.0% | 0.02% | +12.5% |
| Q3 2020 | $6,717,000 | +0.4% | 103,321 | +12.9% | 0.02% | -5.9% |
| Q2 2020 | $6,689,000 | +66.7% | 91,498 | -0.2% | 0.02% | +70.0% |
| Q2 2019 | $4,013,000 | -68.3% | 91,638 | -62.7% | 0.01% | -67.7% |
| Q1 2019 | $12,649,000 | +1204.0% | 245,758 | +837.3% | 0.03% | +933.3% |
| Q4 2018 | $970,000 | – | 26,220 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 900,844 | $136,181,000 | 79.57% |
| RP Management, LLC | 1,111,111 | $167,967,000 | 77.60% |
| JET CAPITAL INVESTORS L P | 1,707,500 | $258,942,000 | 53.95% |
| Alpine Global Management, LLC | 373,999 | $56,537,000 | 13.23% |
| Chicago Capital Management, LLC | 154,585 | $23,443,000 | 12.75% |
| FIFTH LANE CAPITAL, LP | 140,000 | $21,164,000 | 11.03% |
| UBS OCONNOR LLC | 3,784,482 | $572,100,000,000 | 10.85% |
| Eversept Partners, LP | 637,139 | $96,316,303 | 8.35% |
| EQUITEC PROPRIETARY MARKETS, LLC | 187,100 | $28,284,000 | 7.45% |
| HARVEST MANAGEMENT LLC | 48,503 | $7,332,000 | 5.92% |